Prevention and Treatment of Venous Thromboembolism in Patients with Acute Intracerebral Hemorrhage

Seminars in Cerebrovascular Diseases and Stroke

Volumn 5, Issue 3, 2005, Pages 189-193

  Tonarelli, Silvina B ^a   Hart, Robert G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

anticoagulant treatment; intracerebral hemorrhage; venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; D DIMER; DABIGATRAN; FONDAPARINUX; HEPARIN; HEPARIN DERIVATIVE; HEPARINOID; IDRAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN INHIBITOR; WARFARIN; XIMELAGATRAN;

ACUTE DISEASE; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; CLINICAL TRIAL; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DRUG SAFETY; HUMAN; HYDRATION; INFERIOR CAVA VEIN; LOW DRUG DOSE; LUNG EMBOLISM; MEDICAL INFORMATION; MOBILIZATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZATION; RISK ASSESSMENT; TREATMENT PLANNING; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

EID: 33745498410     PISSN: 15289931     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.scds.2006.01.008     Document Type: Article

References (54)

1. Mayer S.A., Brun N.C., Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 (2005) 777-785
2. Gregory P.C., and Kuhlemeier K.V. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil 82 (2003) 364-369
3. Bamford J., Sandercock P., Dennis M., et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire community stroke project 1981-1986. Part 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 53 (1990) 16-22
4. Dickmann U., Voth E., Schicha H., et al. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr 66 (1988) 1182-1183
5. Wasay M., Kahn S., Zaki K.S., et al. A non-randomized evaluation of safety and efficacy of heparin for prevention of deep venous thrombosis in patients with intracerebral hemorrhage. Neurology 60 suppl 1 (2003) 231 (abstract)
6. Wijdicks E.F., and Scott J.P. Pulmonary embolism associated with acute stroke. Mayo Clin Proc 72 (1997) 297-300
7. Bath P.M., Lindenstrom E., Boysen G., et al. Tinzaparin in acute ischaemic stroke (TAIST). a randomised aspirin-controlled trial. Lancet 358 (2001) 702-710
8. Davenport R.J., Dennis M.S., Wellwood I., et al. Complications after acute stroke. Stroke 27 (1996) 415-420
9. International Stroke Trial Collaborative Group. The International Stroke Trial (IST). a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349 (1997) 1569-1581
10. Fraser D.G., Moody A.R., Morgan P.S., et al. Diagnosis of lower-limb deep venous thrombosis. a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 136 (2002) 89-98
11. Kelly J., Rudd A., Lewis R.R., et al. Screening for proximal deep vein thrombosis after acute ischemic stroke. a prospective study using clinical factors and plasma D-dimers. J Thromb Haemost 2 (2004) 1321-1326
12. Harvey R.L., Roth E.J., Yarnold P.R., et al. Deep vein thrombosis in stroke. the use of plasma D-dimer level as a screening test in the rehabilitation setting. Stroke 27 (1996) 1516-1520
13. Yablon S.A., Rock W.A., Nick T.G., et al. Deep vein thrombosis. prevalence and risk factors in rehabilitation admissions with brain injury. Neurology 63 (2004) 485-491
14. Boeer A., Voth E., Henze T., et al. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 54 (1991) 466-467
15. Davis S.M., and Donnan G.A. Effective prophylaxis for deep venous thrombosis after stroke. both low-dose anticoagulation and stockings for most cases. Stroke 35 (2004) 2910
16. Dennis M.S. Effective prophylaxis for deep vein thrombosis after stroke: low-dose anticoagulation rather than stockings alone: against. Stroke 35 (2004) 2912-2913
17. Adams H.P. Effective prophylaxis for deep vein thrombosis after stroke: low-dose anticoagulation rather than stockings alone: for. Stroke 35 (2004) 2911-2912
18. Mazzone C., Chiodo G.F., Sandercock P., et al. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev (2004) CD001922
19. Lacut K., Bressollette L., Le Gal G., et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65 (2005) 865-869
20. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST. randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349 (1997) 1641-1649
21. Chen Z.M., Sandercock P., Pan H.C., et al. Indications for early aspirin use in acute ischemic stroke. a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 31 (2000) 1240-1249
22. Keir S.L., Wardlaw J.M., Sandercock P.A.G., et al. Antithrombotic therapy in patients with any form of intracranial haemorrhage. a systematic review of the available controlled studies. Cerebrovasc Dis 14 (2002) 197-206
23. Buller H.R., Agnelli G., Hull R.D., et al. Antithrombotic therapy for venous thromboembolic disease. the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 suppl 3 (2004) 401S-428S
24. Kelly J., Hunt B.J., Lewis R.R., et al. Anticoagulation or inferior vena cava filter placement for patients with primary intracerebral hemorrhage developing venous thromboembolism?. Stroke 34 (2003) 2999-3005
25. Cohen D.L. Treating thrombotic complications in patients with primary intracerebral haemorrhage. J R Coll Physicians Lond 32 (1998) 417-419
26. Barton A.L., and Dudley N.J. Caval filter placement for pulmonary embolism in a patient with a deep vein thrombosis and primary intracerebral haemorrhage. Age Ageing 31 (2002) 144-146
27. Philbrick J.T., and Becker D.M. Calf deep venous thrombosis. a wolf in sheep's clothing?. Arch Intern Med 148 (1988) 2131-2138
28. Masuda E.M., Kessler D.M., Kistner R.L., et al. The natural history of calf vein thrombosis. lysis of thrombi and development of reflux. J Vasc Surg 28 (1998) 67-73 discussion 73-74
29. Mayer S.A., Sacco R.L., Shi T., et al. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology 44 (1994) 1379-1384
30. Brott T., Broderick J., Kothari R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28 (1997) 1-5
31. Fujii Y., Tanaka R., Takeuchi S., et al. Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 80 (1994) 51-57
32. Leira R., Dávalos A., Silva Y., et al. Early neurologic deterioration in intracerebral hemorrhage. predictors and associated factors. Neurology 63 (2004) 461-467
33. Bae H.-G., Jeong D.-S., Doh J.-W., et al. Recurrence of bleeding in patients with hypertensive intracerebral hemorrhage. Cerebrovasc Dis 9 (1999) 102-108
34. Buhl R., Barth H., and Mehdorn H.M. Risk of recurrent intracerebral hemorrhages. Neurol Res 25 (2003) 853-856
35. Bae H.-G., Lee K.-S., Yun I.-G., et al. Rapid expansion of hypertensive intracerebral hemorrhage. Neurosurgery 31 (1992) 35-41
36. Wijdicks E.F., and Fulgham J.R. Acute fatal deterioration in putaminal hemorrhage. Stroke 26 (1995) 1953-1955
37. Bailey R.D., Hart R.G., Benavente O., et al. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 56 (2001) 773-777
38. Passero S., Burgalassi L., D'Andrea P., et al. Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 26 (1995) 1189-1192
39. Eckman M.H., Rosand J., Knudsen K.A., et al. Can patients be anticoagulated after intracerebral hemorrhage?. a decision analysis. Stroke 34 (2003) 1710-1716
40. Decousus H., Leizorovicz A., Parent F., et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338 (1998) 409-415
41. Chapman N., Huxley R., Anderson C., et al. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history. the PROGRESS Trial. Stroke 35 (2004) 116-121
42. Hart R.G., Tonarelli S.B., and Pearce L.A. Avoiding central nervous system bleeding during antithrombotic therapy. recent data and ideas. Stroke 36 (2005) 1588-1593
43. Smith E.E., Rosand J., Knudsen K.A., et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 59 (2002) 193-197
44. Fan Y.H., Zhang L., Lam W.W., et al. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 34 (2003) 2459-2462
45. O'Donnell H.C., Rosand J., Knudsen K.A., et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 342 (2000) 240-245
46. Cheng J.W. Fondaparinux. a new antithrombotic agent. Clin Ther 24 (2002) 1757-1769 discussion 1719
47. Büller H.R., Davidson B.L., Decousus H., et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis. a randomized trial. Ann Intern Med 140 (2004) 867-873
48. Bauersachs R.M. Fondaparinux. an update on new study results. Eur J Clin Invest 35 suppl 3 (2005) 27-32
49. Schulman S. The role of ximelagatran in the treatment of venous thromboembolism. Pathophysiol Haemost Thromb 34 suppl 3 (2005) 18-24
50. Broderick J.P., Adams H.P., Barsan W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage. a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30 (1999) 905-915
51. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism. the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 suppl 3 (2004) 338S-400S
52. Albers G.W., Amarenco P., Easton J.D., et al. Antithrombotic and thrombolytic therapy for ischemic stroke. the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 suppl 3 (2004) 483S-512S
53. Toni D., Chamorro A., Kaste M., et al. Acute treatment of ischaemic stroke. European Stroke Initiative. Cerebrovasc Dis 17 suppl 2 (2004) 30-46
54. Cvoro V., and Mead G.E. Inferior vena caval filters or anticoagulation for patients with haemorrhagic stroke complicated by venous thromboembolism?. Age Ageing 31 (2002) 85-86